Search

Search Constraints

You searched for: Author/Creator Milella, M.

Search Results

1. 2178 Locoregional treatment for advanced biliary tract cancer (aBTC): Evaluation of efficacy and safety. (September 2015)

2. 2334 Nab Paclitaxel (Nab-P) and Gemcitabine (G) as first line chemotherapy (CT) in advanced pancreatic cancer (APDAC) patients (pts): An Italian "real life" study. (September 2015)

3. 2335 Analysis of activity, efficacy and safety of first line Nab Paclitaxel (Nab-P) and Gemcitabine (G) in advanced pancreatic cancer (APDAC) frail and elderly patients (pts). (September 2015)

4. A different perspective on sofosbuvir‐ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital‐c network study. Issue 1 (30th August 2017)

6. Changing HCV patient profiles: insights from a large multinational real-world sofosbuvir/velpatasvir (SOF/VEL) dataset. (March 2023)

7. Chemotherapy and subsequent stereotactic body radiotherapy (SBRT) as a multimodal neoadjuvant approach for selected borderline resectable / locally advanced pancreatic adenocarcinoma. (2020)

8. Detecting actionable PIK3CA mutations through next-generation sequencing (NGS) in hormone receptor positive (HR+)/HER2-negative advanced/metastatic breast cancer (MBC): a real-life experience. (November 2022)

10. Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma. Issue 1 (January 2021)